Neurotrack is building the cognitive health platform of the future, giving people direct access to tools and technology to assess, strengthen, and monitor their cognitive health. The company was co-founded in 2012 by Elli Kaplan, and leading neuroscientists and researchers Stuart Zola, Ph.D., Elizabeth Buffalo, Ph.D., and Cecelia Manzanares.
Neurotrack partners with Sompo Holdings to launch the Neurotrack Cognitive Health Program to policyholders in Japan.
Series C Funding
Neurotrack raises $21M in Series C funding round.
Research Grant Awarded
The National Institute of Aging, a division of the U.S. National Institutes of Health, awards Neurotrack with a $3.3M research grant.
Dai-ichi Life Partnership
Neurotrack partners with Dai-ichi Life to launch its new dementia insurance product.
Series B Funding
Neurotrack raises $13.7M in Series B funding round.
Series A Funding
Neurotrack raises $7.5M in Series A funding round.
Neurotrack is Founded
Elli Kaplan co-founds Neurotrack with a mission to give people everywhere the tools to assess their risk for cognitive decline.
Co-Founder and CEO
“What we’re building at Neurotrack matters - to families here and around the world, including mine.”
Nick Bott, Psy.D.
Chief Science Officer
“We are working on problems that are not only technically challenging, and biologically interesting but clinically meaningful and globally relevant.”
Chief Business Officer
“The financial implications of Alzheimer's are tremendous and daunting. I believe we have the ability to change lives while also making a positive economic impact on our healthcare systems.”
Chief Financial Officer
Japan Country Manager
“Leading the way to create a new society through innovation. Not easy, but worth it.”
Scott Andrews, Ph.D.
Vice President, Engineering
“I'm excited to be using the latest machine learning technology to build a cutting-edge platform that helps people facing cognitive decline.”
Vice President, Product
“Today's choices impact our future cognition. I'm inspired to design a program that empowers people to take control of their long-term cognitive health.”
Jordan Glenn, Ph.D.
Vice President, Clinical Development
“Alzheimer's isn't about just treatment, but prevention. Neurotrack is working to help stop Alzheimer's Disease before it even begins.”
John Harrison, Ph.D.
Metis Cognition Ltd.
Richard Isaacson, M.D.
Alzheimer's Prevention Clinic, Weill Cornell Medicine
Vice President of Clinical Development and US Site Head
Mike Poole, M.D.
Dorene Rentz, Psy.D.
Center for Alzheimer Research and Treatment, Brigham and Women's Hospital
Stuart Zola Ph.D.
Interim Provost Executive Vice President Academic Affairs
Professor, Psychiatry & Behavioral Sciences
Emory University School of Medicine
Elizabeth Buffalo Ph.D.
Professor, Department of Physiology & Biophysics
Professor, Department of Physiology & Biophysics University of Washington School of Medicine
Chief, Neuroscience Division
Washington National Primate Research Center
Yerkes National Primate Research Center Emory University
Sign up here and we'll send you a product overview and let you know when it's ready for download.